Advocate Health is seeking approval for a nearly $100 million comprehensive cancer center at Advocate Lutheran General Hospital in Park Ridge, Illinois. This initiative aims to consolidate outpatient oncology services currently scattered across the hospital campus into a centralized facility. The proposed project includes a two-floor addition to the hospital’s Center for Advanced Care and an upgrade of existing outpatient laboratory space.
The plan outlines approximately 77,605 square feet of new construction and modernization of around 5,813 square feet of existing facilities, bringing the total to roughly 83,000 square feet, as detailed in the application submitted to the Illinois Health Facilities & Services Review Board. Hospital officials indicate that the revamped complex will enhance infusion, transplant, and cellular-therapy capacity while streamlining hematology and oncology clinics to reduce patient travel across the campus. Completion is projected by the end of 2028.
Project Details and Objectives
According to the proposal, the cancer center aims to centralize multiple hematology and oncology clinics under one roof. This includes an expanded transplant and cellular-therapy program, enhanced infusion services, and a modernized outpatient laboratory. The design also incorporates room for clinical trials, supportive care, and patient navigation services, making it a comprehensive resource for cancer treatment.
Advocate’s plans come at a time when competition in cancer care is intensifying across the Chicago area. The ongoing expansion reflects a significant investment in outpatient cancer services, which are increasingly viewed as essential by health systems.
Regional Context and Competition
In the Chicago market, Advocate’s Park Ridge proposal joins a growing trend among healthcare providers to improve cancer care access. Duly Health & Care is set to open the Brian Moran Cancer Institute in Lisle on December 15, 2025. This facility represents a major step in enhancing suburban oncology access.
On the South Side, the University of Chicago Medicine is constructing a 575,000-square-foot freestanding cancer pavilion, slated for completion in 2027. This development is expected to significantly increase both inpatient and outpatient cancer care capacity. Other organizations, including Endeavor Health, Northwestern, and Rush, are also advancing their oncology services, indicating a robust commitment to improving cancer care infrastructure.
The Illinois Health Facilities & Services Review Board will evaluate Advocate’s proposal, reviewing community needs and ensuring no duplicative services are planned. If accepted, the board will facilitate a period for public comment and potentially a hearing before making a final decision on the project.
For residents in Park Ridge and surrounding areas, the establishment of this comprehensive cancer center promises increased access to oncology services and infusion capacity within a single facility. This initiative not only aims to enhance patient care but also reflects a broader recognition of the importance of outpatient cancer treatment in healthcare investment strategies. Advocate Health has yet to comment on specific details regarding the timeline or staffing for the new center.
